Delivery Order SPE2DB20D3103-SPE2DB22FN2L4
Award Date 4/4/22
Potential Completion Date 4/5/22
Potential Value $4.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Zortress 0.5 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 14, 2022, with a ceiling value of $3,506.60 and an ultimate completion date of January 18, 2022. The contract is a delivery order with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4556351812 - ZORTRESS 0.5 MG TABLET UD 60S. The contract, valued at $14,738.90, was awarded on February 23, 2022, with a completion date of February 24, 2022. The contract is a Delivery Order under a Firm Fixed Price arrangement. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a...
- This federal contract award, valued at $3,227.47, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product ZORTRESS 1 MG TABLET UD 60S, with a period of performance through March 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support...
- This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAT21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zortress 1 mg tablet units, valued at $18,573.23. It is a Firm Fixed Price Delivery Order contract with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,803.97 firm fixed-price delivery order is for the supply of Zortress 0.75 mg tablet medication, with a period of performance ending on July 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $3,956.65, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 IDC running through November 2026. The contract is for the supply of pharmaceutical products, including the drug Zortress in 0.75 mg tablet form. As the award is not designated with a set-aside, it appears to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,003.90 firm fixed-price delivery order is for the supply of the medication Zortress 0.25 mg tablet. The contract has an ultimate completion date of July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,123.89 firm fixed-price delivery order is for the pharmaceutical product ZORTRESS 0.5 MG TABLET UD 60S, with a period of performance through July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,592.83 firm fixed-price delivery order is for the supply of Zortress 0.25 mg tablet medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,005.00, is for the delivery of the pharmaceutical product ZORTRESS 0.5 MG TABLET UD 60S. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and has a firm fixed price and an ultimate completion date of June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...